These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28689844)

  • 21. [Advances in the management of asthma].
    Westhölter D; Reuter S; Taube C
    Laryngorhinootologie; 2024 Jul; 103(7):500-505. PubMed ID: 38330996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotype-Driven Therapeutics in Severe Asthma.
    Opina MT; Moore WC
    Curr Allergy Asthma Rep; 2017 Feb; 17(2):10. PubMed ID: 28233153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials.
    Wang FP; Xiong XF; Liu T; Li SY; Cheng DY; Mao H
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):318-330. PubMed ID: 27677499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current Asthma Treatment in Light of New Asthma Guidelines].
    Lommatzsch M
    Dtsch Med Wochenschr; 2018 Jun; 143(11):806-810. PubMed ID: 29807381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New clues to asthma therapies.
    Vogel G
    Science; 1997 Jun; 276(5319):1643-6. PubMed ID: 9206826
    [No Abstract]   [Full Text] [Related]  

  • 27. Personalized Approach to Severe Asthma.
    Heffler E; Canonica GW; Diamant Z; Fonseca J; Malinovschi A
    Biomed Res Int; 2018; 2018():2465172. PubMed ID: 30671448
    [No Abstract]   [Full Text] [Related]  

  • 28. [New additions to asthma therapy. Satellite Symposium at the 24th Congress of the German Society of Allergology. Hamburg, 6 September 1997].
    Laryngorhinootologie; 1997 Nov; 76(11 Suppl):1-4. PubMed ID: 9431357
    [No Abstract]   [Full Text] [Related]  

  • 29. Advances in adult asthma diagnosis and treatment in 2014.
    Apter AJ
    J Allergy Clin Immunol; 2015 Jan; 135(1):46-53. PubMed ID: 25567042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy and asthma.
    Finegold I
    J Asthma; 2003; 40 Suppl():31-5. PubMed ID: 12817927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Asthma phenotypes and phenotyp-specific treatment].
    Rothe T
    Praxis (Bern 1994); 2013 Feb; 102(4):211-8. PubMed ID: 23399604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selecting the right biologic for your patients with severe asthma.
    Manka LA; Wechsler ME
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):406-413. PubMed ID: 30056149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Total control of asthma].
    Pérez Martín J
    Rev Alerg Mex; 2004; 51(5):163-5. PubMed ID: 15794404
    [No Abstract]   [Full Text] [Related]  

  • 35. Who (if anyone) actually gets steroid-sparing effects from aeroallergen immunotherapy?
    Adkinson NF
    J Allergy Clin Immunol; 2010 Nov; 126(5):950-1. PubMed ID: 21050943
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of asthma in adults: current therapy and future directions.
    Green RH; Brightling CE; Pavord ID; Wardlaw AJ
    Postgrad Med J; 2003 May; 79(931):259-67. PubMed ID: 12782771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab.
    Staton TL; Arron JR; Olsson J; Holweg CTJ; Matthews JG; Choy DF
    J Allergy Clin Immunol; 2017 May; 139(5):1682-1684.e3. PubMed ID: 28238745
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. British Guideline on the Management of Asthma.
    British Thoracic Society Scottish Intercollegiate Guidelines Network
    Thorax; 2008 May; 63 Suppl 4():iv1-121. PubMed ID: 18463203
    [No Abstract]   [Full Text] [Related]  

  • 40. Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.
    Katial RK; Bensch GW; Busse WW; Chipps BE; Denson JL; Gerber AN; Jacobs JS; Kraft M; Martin RJ; Nair P; Wechsler ME
    J Allergy Clin Immunol Pract; 2017; 5(2S):S1-S14. PubMed ID: 28143691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.